Literature DB >> 11146581

Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.

F Leoni, S Ciolli, C Nozzoli, V Santini, R Fanci, P Rossi Ferrini .   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11146581

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.

Authors:  Elisabeth J Walsby; Steven J Coles; Steven Knapper; Alan K Burnett
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

2.  All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage.

Authors:  Zhifei Xu; JinJin Shao; Lin Li; Xueming Peng; Min Chen; Guanqun Li; Hao Yan; Bo Yang; Peihua Luo; Qiaojun He
Journal:  BMC Cancer       Date:  2016-01-05       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.